Investor Information

IR banner
Webcast ImageWebcast - Replay
Q1 2016 Express Scripts Holding Co Earnings Conference Call
04/26/16 at 8:30 a.m. ET
Q1 2016 Express Scripts Holding Co Earnings Conference Call
Tuesday, April 26, 2016 8:30 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar

Business Overview

Business Overview
At Express Scripts we believe in practicing pharmacy smarter. We put medicine within reach of tens of millions of people by aligning with our customers, taking bold action and delivering patient-centered care to make better health more affordable and accessible.

Headquartered in St. Louis, Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery pharmacy care, specialty pharmacy care, specialty benefit management, benefit-design consultation, drug utilization review, formulary management and medical and drug data analysis services. Express Scripts also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services.

Stock chart for: ESRX.O.  Currently trading at $73.73 with a 52 week high of $94.61 and a 52 week low of $65.55.
ESRX (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$73.73
Change (%) Stock is Down 1.2 (1.60%)
Volume3,673,174
Data as of 04/29/16 4:00 p.m. ET
Refresh quote
Recent Press Releases
Express Scripts Announces 2016 First Quarter Results; Increases 2016 Guidance Range: Raises Mid-Point; Provides 2016 Second Quarter Guidance - 04/25/2016 - 4:09 p.m.
ST. LOUIS, April 25, 2016 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) announced 2016 first quarter net income of $526.1 million, or $0.81 per diluted share.  2016 first quarter adju... 
Express Scripts Holding Company Announces First Quarter Earnings Conference Call - 04/06/2016 - 5:01 p.m.
ST. LOUIS, April 06, 2016 (GLOBE NEWSWIRE) -- Express Scripts Holding Company (Nasdaq:ESRX) announced today its intention to release its first quarter earnings on Monday, April 25, 2016 after the ma... 
U.S. Workers' Compensation Prescription Drug Spending Increased 2.2 Percent in 2015 - 04/05/2016 - 8:00 a.m.
Opioids Remain Costliest Therapy Class, Yet Express Scripts Management Programs Drove Down Utilization For Fifth Consecutive Year ST. LOUIS, April 5, 2016 /PRNewswire/ -- Rising drug prices contr... 
Increase in U.S. Drug Spending Slowed to 5.2 Percent in 2015 Through Cost-Saving Solutions, Specialized Care - 03/14/2016 - 8:00 p.m.
- Express Scripts solutions slowed increases in overall drug spending despite price inflation of greater than 20 percent on more than one-third of brand-name medications in 2015 - For Express Scrip... 
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever Express Scripts Holding Co posts new information to the site. Just enter your e-mail address and click Submit.
 

Tax Consequences of Express Scripts and Medco Merger

Investor Overview
Learn more about Express Scripts and find corporate and shareholder information.

Data provided by Nasdaq. Minimum 15 minutes delayed.
Print Page Print | E-mail Page E-mail Page | RSS Feeds RSS | E-mail Alerts Alerts | IR Contacts IR Contacts | Financial Tear Sheet Financial Tear Sheet